A detailed history of Cerity Partners LLC transactions in Incyte Corp stock. As of the latest transaction made, Cerity Partners LLC holds 19,157 shares of INCY stock, worth $1.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,157
Previous 13,620 40.65%
Holding current value
$1.37 Million
Previous $825,000 53.45%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$57.33 - $68.61 $317,436 - $379,893
5,537 Added 40.65%
19,157 $1.27 Million
Q2 2024

Aug 13, 2024

SELL
$51.18 - $63.75 $445,521 - $554,943
-8,705 Reduced 38.99%
13,620 $825,000
Q1 2024

May 14, 2024

BUY
$56.55 - $66.59 $977,523 - $1.15 Million
17,286 Added 343.04%
22,325 $1.27 Million
Q4 2023

Jan 26, 2024

BUY
$52.16 - $64.19 $262,834 - $323,453
5,039 New
5,039 $316,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.